Skip to main content

Table 4 Frequency of leiomyoma degeneration in postmenopausal and premenopausal women

From: Possible significance of degeneration and decreased expression of progesterone receptor in postmenopausal uterine leiomyoma

 

Group a

(n = 13)

Group b

(n = 23)

Group c

(n = 78)

Age (years)

58 (54–70)

69 (65–76)

45.5 (43–48)

Maximum diameter of leiomyoma (cm)

11.5 (9–17)

3.0 (1.8–5)

7.5 (6–9.7)

Degeneration

12 (92%)

15 (65%)

37 (47%)

 Hyaline

7 (53%)

13 (56%)

16 (21%)

 Myxoid

3 (23%)

0

1 (1.3%)

 Edematous

4 (31%)

1 (4.3%)

12 (15%)

 Calcification

0

2 (8.7%)

2 (2.5%)

 Fibrosis

0

0

13 (17%)

 Hemorrhagic (Red degeneration)

0

0

4 (5.1%)

  1. Values are presented as median (interquartile range) or number (%). Group a: Postmenopausal women who underwent surgery for leiomyoma; group b: Postmenopausal women incidentally complicated with leiomyoma who underwent hysterectomy; group c: Premenopausal women who underwent hysterectomy for leiomyoma without hormonal treatment